Type 1 Invariant Natural Killer T Cells Drive Lung Fibrosis

This publication has 16 references indexed in Scilit:

• A circulating subset of iNKT cells mediates antitumor and antiviral immunity
  Science Immunology, 2022
• Impairment of the NKT–STAT1–CXCL9 Axis Contributes to Vessel Fibrosis in Pulmonary Hypertension Caused by Lung Fibrosis
  American Journal of Respiratory and Critical Care Medicine, 2022
• BAL Is Safe and Well Tolerated in Individuals with Idiopathic Pulmonary Fibrosis: An Analysis of the PROFILE Study
  American Journal of Respiratory and Critical Care Medicine, 2021
• Idiopathic Pulmonary Fibrosis
  New England Journal of Medicine, 2018
• Protective role of NKT cells and macrophage M2-driven phenotype in bleomycin-induced pulmonary fibrosis
  Inflammopharmacology, 2017
• CXCR6 marks a novel subset of T-betloEomeshi natural killer cells residing in human liver
  Scientific Reports, 2016
• Invariant natural killer T cells contribute to chronic-plus-binge ethanol-mediated liver injury by promoting hepatic neutrophil infiltration
  Cellular & Molecular Immunology, 2015
• Inhibition of type I natural killer T cells by retinoids or following sulfatide‐mediated activation of type II natural killer T cells attenuates alcoholic liver disease in mice
  Hepatology, 2014
• Role of type 1 natural killer T cells in pulmonary immunity
  Mucosal Immunology, 2013
• Sulfatide-Mediated Activation of Type II Natural Killer T Cells Prevents Hepatic Ischemic Reperfusion Injury In Mice
  Gastroenterology, 2011